Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572-580. doi:10.1016/S0140-6736(17)32520-5.
Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study. PLoS Med. 2018;15(3):e1002513. doi:10.1371/journal.pmed.1002513.
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data. PLoS Med. 2018;15(3):e1002538. doi:10.1371/journal.pmed.1002538.
Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults. PLoS Med. 2017;14(10):e1002404. doi:10.1371/journal.pmed.1002404.
Impact of missed treatment opportunities on outcomes in hospitalised patients with heart failure. Open Heart. 2017;4(2):e000726. doi:10.1136/openhrt-2017-000726.
Trend of Socio-Demographic Index and Mortality Estimates in Iran and its Neighbors, 1990-2015; Findings of the Global Burden of Diseases 2015 Study. Arch Iran Med. 2017;20(7):419-428.
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1-25. doi:10.1016/j.jacc.2017.04.052.
A cardiac contouring atlas for radiotherapy. Radiother Oncol. 2017;122(3):416-422. doi:10.1016/j.radonc.2017.01.008.
Patients with coronary heart disease and very low blood pressure are at increased risk of cardiovascular events. Evid Based Med. 2017;22(2):73. doi:10.1136/ebmed-2016-110648..
Subclinical atrial fibrillation in need of more assertive evidence. Eur Heart J. 2017. doi:10.1093/eurheartj/ehx122..
Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke. Stroke. 2016;47(6):1429-35. doi:10.1161/STROKEAHA.116.012658.
Graphical displays for meta-analysis. Heart. 2016..
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545-1602..
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544..
Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1775-1812..
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1603-1658..
Creating connections – the development of a mobile-health monitoring system for heart failure: Qualitative findings from a usability cohort study. Digital Health. 2016;2.
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIVLancet HIVLancet HIV. 2016;3:e361-87.
Heartbeat: Is atrial fibrillation ablation effective in patients with hypertrophic cardiomyopathy?. Heart. 2016;102:1511-2..
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob Health. 2016.
Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study. European Heart Journal. 2016..
Blood pressure lowering for cardiovascular disease - Authors' reply. Lancet. 2016;388:126-7..
Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart. 2016.
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. Heart. 2016;102:1750-1756.